Introduction: This study aimed to survey the discrimination power of parameters from
cerebrospinal fluid (CSF) biomarkers, fluorodeoxyglucose uptake on PET (FDG-PET) …

Alzheimer's Disease (AD) and mild cognitive impairment (MCI) are associated with
widespread changes in brain structure and function, as indicated by magnetic resonance …

Background Cognitive decline has been found to be associated with gray matter atrophy
and disruption of functional neural networks in Alzheimer's disease (AD) in structural and …

Background: Resting-state functional magnetic resonance imaging (RS-fMRI) appears as a
promising imaging technique to identify early biomarkers of Alzheimer type …

Among the range of neuroimaging techniques available that may provide insight into
Alzheimer's disease (AD), resting-state functional magnetic resonance imaging (rsfMRI) and …

Mild cognitive impairment (MCI) often precedes Alzheimer's Dementia (AD), and in a high
proportion of individuals affected by MCI, there are already neuropathological processes …

Background At present, clinical use of MRI in Alzheimer's disease (AD) is mostly focused on
the assessment of brain atrophy, namely in the hippocampal region. Despite this, multiple …

Alzheimer's disease (AD) is associated with disruptions in brain activity and networks.
However, there is substantial inconsistency among studies that have investigated functional …

Objective Early Alzheimer's disease (AD) diagnosis remains challenging, necessitating
specific biomarkers for timely detection. This study aimed to identify such biomarkers and …

Accurate diagnosis of the initial phase of Alzheimer's disease (AD) is essential and crucial.
The objective of this research was to employ efficient biomarkers for the diagnostic analysis …